TY - JOUR
T1 - Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses
AU - RECOVAC Consortium
AU - den Hartog, Yvette
AU - Malahe, S Reshwan K
AU - Rietdijk, Wim J R
AU - Dieterich, Marjolein
AU - Gommers, Lennert
AU - Geers, Daryl
AU - Bogers, Susanne
AU - van Baarle, Debbie
AU - Diavatopoulos, Dimitri A
AU - Messchendorp, A Lianne
AU - van der Molen, Renate G
AU - Remmerswaal, Ester B M
AU - Bemelman, Frederike J
AU - Gansevoort, Ron T
AU - Hilbrands, Luuk B
AU - Sanders, Jan-Stephan
AU - GeurtsvanKessel, Corine H
AU - Kho, Marcia M L
AU - Reinders, Marlies E J
AU - de Vries, Rory D
AU - Baan, Carla C
N1 - © 2023. The Author(s).
PY - 2023/5/17
Y1 - 2023/5/17
N2 - Cytokines are regulators of the immune response against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, the contribution of cytokine-secreting CD4
+ and CD8
+ memory T cells to the SARS-CoV-2-specific humoral immune response in immunocompromised kidney patients is unknown. Here, we profiled 12 cytokines after stimulation of whole blood obtained 28 days post second 100 μg mRNA-1273 vaccination with peptides covering the SARS-CoV-2 spike (S)-protein from patients with chronic kidney disease (CKD) stage 4/5, on dialysis, kidney transplant recipients (KTR), and healthy controls. Unsupervised hierarchical clustering analysis revealed two distinct vaccine-induced cytokine profiles. The first profile was characterized by high levels of T-helper (Th)
1 (IL-2, TNF-α, and IFN-γ) and Th
2 (IL-4, IL-5, IL-13) cytokines, and low levels of Th
17 (IL-17A, IL-22) and Th
9 (IL-9) cytokines. This cluster was dominated by patients with CKD, on dialysis, and healthy controls. In contrast, the second cytokine profile contained predominantly KTRs producing mainly Th
1 cytokines upon re-stimulation, with lower levels or absence of Th
2, Th
17, and Th
9 cytokines. Multivariate analyses indicated that a balanced memory T cell response with the production of Th
1 and Th
2 cytokines was associated with high levels of S1-specific binding and neutralizing antibodies mainly at 6 months after second vaccination. In conclusion, seroconversion is associated with the balanced production of cytokines by memory T cells. This emphasizes the importance of measuring multiple T cell cytokines to understand their influence on seroconversion and potentially gain more information about the protection induced by vaccine-induced memory T cells.
AB - Cytokines are regulators of the immune response against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, the contribution of cytokine-secreting CD4
+ and CD8
+ memory T cells to the SARS-CoV-2-specific humoral immune response in immunocompromised kidney patients is unknown. Here, we profiled 12 cytokines after stimulation of whole blood obtained 28 days post second 100 μg mRNA-1273 vaccination with peptides covering the SARS-CoV-2 spike (S)-protein from patients with chronic kidney disease (CKD) stage 4/5, on dialysis, kidney transplant recipients (KTR), and healthy controls. Unsupervised hierarchical clustering analysis revealed two distinct vaccine-induced cytokine profiles. The first profile was characterized by high levels of T-helper (Th)
1 (IL-2, TNF-α, and IFN-γ) and Th
2 (IL-4, IL-5, IL-13) cytokines, and low levels of Th
17 (IL-17A, IL-22) and Th
9 (IL-9) cytokines. This cluster was dominated by patients with CKD, on dialysis, and healthy controls. In contrast, the second cytokine profile contained predominantly KTRs producing mainly Th
1 cytokines upon re-stimulation, with lower levels or absence of Th
2, Th
17, and Th
9 cytokines. Multivariate analyses indicated that a balanced memory T cell response with the production of Th
1 and Th
2 cytokines was associated with high levels of S1-specific binding and neutralizing antibodies mainly at 6 months after second vaccination. In conclusion, seroconversion is associated with the balanced production of cytokines by memory T cells. This emphasizes the importance of measuring multiple T cell cytokines to understand their influence on seroconversion and potentially gain more information about the protection induced by vaccine-induced memory T cells.
U2 - 10.1038/s41541-023-00664-4
DO - 10.1038/s41541-023-00664-4
M3 - Article
C2 - 37198189
SN - 2059-0105
VL - 8
JO - npj Vaccines
JF - npj Vaccines
M1 - 70
ER -